Shop
Showing 151–180 of 429 results
-
VentureFutureChem Co., Ltd.
-
-
-
LargeGC Cell
GC Cell is a company in cell and gene therapy innovation, offering a holistic approach that encompass everything from research and development to bring products to market. They carry out integrated R&D under the goal of commercialization of cell therapy products, from fundamental research to GMP production and product analysis for clinical studies.
-
VentureGencellmed
GenCellMed is a company that was established as a result of the merger between ‘GenCellMed’, a liquid biopsy company, and ‘ZeroMix’, a genome analysis company. They are currently focusing on the commercialization of the ADC platform business.
-
-
VentureGeneKore
-
-
VentureGeneMedicine
GeneMedicine(GM) is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies, aiming to transform the therapeutic outcomes for cancer patients.
-
-
VentureGeneroath
Generoath is a company that develops drugs for treating neurological diseases. Their pipeline includes products like GO-101, GO-102, GO-201, GO-301, GO-401 for diseases such as Parkinson’s disease, amyotrophic lateral sclerosis, retinal degenerative disease, epilepsy, and companion biomarker.
-
-
-
SMEGENOFOCUS
GenoFocus is a company that develops special enzymes and microbiome therapeutics. They have developed a range of products including industrial special enzymes such as lactase, catalase, and proteinase K.
-
-
VentureGenome & Company
Genome & Company is a pharmaceutical bio company that focuses on the research and development of immune anti-cancer drugs and new target microbiome drugs.
-
-
VentureGI BIOME
GI BIOME is a company that focuses on the research and development of microbiome therapeutics. They are involved in various areas including the mucosal immune system and microbiome.
-
VentureGI Cell
GI Cell is focused on developing innovative and competitive cell therapies. They aim to provide safe, effective, and superior immune cell therapies with cutting-edge technology.
-
VentureGI Innovation
GI Innovation is a biopharmaceutical company that aims to develop innovative biologics to cure diseases. They are working on various projects based on their 3S strategy: Science, Strategy, and Speed. They aim to create a synergy in new drug development through solid intermediary research and strategic collaboration with global pharmaceutical companies.
-
-
-
-
VentureGoodTCells
Good T Cells is developing First-In-Class immunotherapeutics and diagnostic reagents against cancer and autoimmune diseases.
-
VentureGPCR Therapeutics, Inc.
-
-
-
-
-
